Posts by: Ana Pamplona PhD

Ana Pamplona PhD

Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.

June 23, 2015August 23, 2016

Novel Drug Shows Promising Results In Lymphoma Treatment

News

During the 13th International Conference on Malignant Lymphoma, held this June in Lugano, Switzerland, promising results were presented relative to a new drug TAK-659, an inhibitor of spleen tyrosine kinase (SYK) with ... Read more

May 29, 2015

Study Investigates The Role of Macrophages and Dendritic Cells in Classical Hodgkin Lymphoma

News

A new study entitled “Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma”, published in PLOS One, assessed the role of macrophages and dendritic cells ... Read more

May 13, 2015May 19, 2015

Plasmablastic Lymphoma Of The Oral Cavity Involving The Breast – A Rare Case Study

News

A rare case study of plasmablastic lymphoma involving the breast entitled “Plasmablastic lymphoma of the oral cavity with breast recurrence: a case report” was published in the BMC Research Notes ... Read more

May 5, 2015September 4, 2015

Hodgkin Lymphoma-Associated Therapy Increases Risk of Cardiovascular Conditions

News

A novel study entitled “Cardiovascular Disease After Hodgkin Lymphoma Treatment40-Year Disease Risk”and published in JAMA Internal Medicine has found that Hodgkin lymphoma survivors have a higher probability of suffering from cardiovascular diseases. ... Read more